Clinical Trial Update: A Single Ascending Dose Study of SYH2082 Injection in Healthy Participants [Phase 1]

View source ↗

Summary

Phase 1 single ascending-dose study of SYH2082 injection in healthy participants to assess safety and pharmacokinetics for overweight or obesity; study status i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• SYH2082 Injection

Snippet

Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Conditions: Overweight or Obesity | Phase 1 | Status: NOT_YET_RECRUITING